{ "cik": 874716, "cik_padded": "0000874716", "entityName": "IDEXX LABORATORIES INC /DE", "fiscal_years": [ { "accn": "0000874716-26-000038", "filed": "2026-02-20", "fiscal_year": 2025, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 1216964000.0, "capex": 124676000.0, "cash": 180070000.0, "cost_of_revenue": 1644123000.0, "eps_diluted": 13.08, "free_cash_flow": 1057129000.0, "gross_profit": 2659579000.0, "net_income": 1059464000.0, "operating_cash_flow": 1181805000.0, "operating_income": 1360031000.0, "revenue": 4303702000.0, "stockholders_equity": 1605383000.0, "total_assets": 3350759000.0, "total_liabilities": 1745376000.0 }, "period_end": "2025-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.6179747110743262, "leverage": 1.087202243950509, "net_margin": 0.24617503721214898, "operating_margin": 0.316014212879981, "revenue_growth_yoy": 0.10422003415519265, "roa_avg2y": 0.3189138439800596, "roa_period_end": 0.3161862730205306, "roe_avg2y": 0.6620210104302314, "roe_period_end": 0.6599446985547996 } }, { "accn": "0000874716-26-000038", "filed": "2026-02-20", "fiscal_year": 2024, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 837034000.0, "capex": 120922000.0, "cash": 288266000.0, "cost_of_revenue": 1518577000.0, "eps_diluted": 10.67, "free_cash_flow": 808079000.0, "gross_profit": 2378927000.0, "net_income": 887867000.0, "operating_cash_flow": 929001000.0, "operating_income": 1128337000.0, "revenue": 3897504000.0, "stockholders_equity": 1595313000.0, "total_assets": 3293443000.0, "total_liabilities": 1698130000.0 }, "period_end": "2024-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.6103719200801333, "leverage": 1.0644494215241773, "net_margin": 0.22780399968800544, "operating_margin": 0.28950246106225935, "revenue_growth_yoy": 0.0646145962540355, "roa_avg2y": 0.270965097641396, "roa_period_end": 0.2695862658014728, "roe_avg2y": 0.57656640289781, "roe_period_end": 0.5565472104847137 } }, { "accn": "0000874716-26-000038", "filed": "2026-02-20", "fiscal_year": 2023, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 71920000.0, "capex": 133631000.0, "cash": 453932000.0, "cost_of_revenue": 1470983000.0, "eps_diluted": 10.06, "free_cash_flow": 772879000.0, "gross_profit": 2189970000.0, "net_income": 845042000.0, "operating_cash_flow": 906510000.0, "operating_income": 1097128000.0, "revenue": 3660953000.0, "stockholders_equity": 1484530000.0, "total_assets": 3259925000.0, "total_liabilities": 1775395000.0 }, "period_end": "2023-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.5981966990562293, "leverage": 1.1959306986049456, "net_margin": 0.23082568937650938, "operating_margin": 0.2996837162345433, "revenue_growth_yoy": 0.08719950916514123, "roa_avg2y": 0.28136694252575045, "roa_period_end": 0.259221301103553, "roe_avg2y": 0.8073905526624172, "roe_period_end": 0.5692320128256081 } }, { "accn": "0000874716-26-000038", "filed": "2026-02-20", "fiscal_year": 2022, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 819711000.0, "capex": 148838000.0, "cash": 112546000.0, "cost_of_revenue": 1362986000.0, "eps_diluted": 8.03, "free_cash_flow": 394146000.0, "gross_profit": 2004338000.0, "net_income": 679089000.0, "operating_cash_flow": 542984000.0, "operating_income": 898765000.0, "revenue": 3367324000.0, "stockholders_equity": 608737000.0, "total_assets": 2746765000.0, "total_liabilities": 2138028000.0 }, "period_end": "2022-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.5952317032753605, "leverage": 3.5122359902552334, "net_margin": 0.20167022834749493, "operating_margin": 0.2669077879051734, "revenue_growth_yoy": 0.04726189291401274, "roa_avg2y": 0.26199583022117423, "roa_period_end": 0.24723228962069924, "roe_avg2y": 1.0457747536245052, "roe_period_end": 1.1155704351797247 } }, { "accn": "0000874716-25-000037", "filed": "2025-02-21", "fiscal_year": 2021, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 746777000.0, "capex": 119549000.0, "cash": 144454000.0, "cost_of_revenue": 1325928000.0, "eps_diluted": 8.6, "free_cash_flow": 635997000.0, "gross_profit": 1889432000.0, "net_income": 744845000.0, "operating_cash_flow": 755546000.0, "operating_income": 932028000.0, "revenue": 3215360000.0, "stockholders_equity": 689992000.0, "total_assets": 2437203000.0, "total_liabilities": 1747211000.0 }, "period_end": "2021-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.5876268909235669, "leverage": 2.532219214135816, "net_margin": 0.23165213226512738, "operating_margin": 0.289867386544586, "revenue_growth_yoy": 0.18794600715643478, "roa_avg2y": 0.3148276203124247, "roa_period_end": 0.3056146738700059, "roe_avg2y": 1.126777502117875, "roe_period_end": 1.079498023165486 } }, { "accn": "0000874716-23-000006", "filed": "2023-02-16", "fiscal_year": 2020, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 182815000.0, "capex": 106958000.0, "cash": 383928000.0, "cost_of_revenue": 1135615000.0, "eps_diluted": 6.71, "free_cash_flow": 541105000.0, "gross_profit": 1571040000.0, "net_income": 581776000.0, "operating_cash_flow": 648063000.0, "operating_income": 694524000.0, "revenue": 2706655000.0, "stockholders_equity": 632088000.0, "total_assets": 2294561000.0, "total_liabilities": 1661766000.0 }, "period_end": "2020-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.5804359994162537, "leverage": 2.6290105175228766, "net_margin": 0.21494279839876157, "operating_margin": 0.25659864297444634, "revenue_growth_yoy": 0.12453612684822186, "roa_avg2y": 0.2819340563057846, "roa_period_end": 0.25354566734116024, "roe_avg2y": 1.437262911627413, "roe_period_end": 0.9204034881219072 } }, { "accn": "0000874716-22-000007", "filed": "2022-02-16", "fiscal_year": 2019, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 301658000.0, "capex": 154969000.0, "cash": 90326000.0, "cost_of_revenue": 1041359000.0, "eps_diluted": 4.89, "free_cash_flow": 304189000.0, "gross_profit": 1365549000.0, "net_income": 427720000.0, "operating_cash_flow": 459158000.0, "operating_income": 552846000.0, "revenue": 2406908000.0, "stockholders_equity": 177473000.0, "total_assets": 1832475000.0, "total_liabilities": 1654650000.0 }, "period_end": "2019-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.5673457398454781, "leverage": 9.32339003679433, "net_margin": 0.1777051719467466, "operating_margin": 0.22969137166854736, "revenue_growth_yoy": 0.08750330962452366, "roa_avg2y": 0.25385302021707956, "roa_period_end": 0.23341109701360183, "roe_avg2y": 5.093117408906883, "roe_period_end": 2.4100567410253952 } }, { "accn": "0000874716-21-000008", "filed": "2021-02-12", "fiscal_year": 2018, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 369319000.0, "capex": 115751000.0, "cash": 123794000.0, "cost_of_revenue": 971700000.0, "eps_diluted": 4.26, "free_cash_flow": 284333000.0, "gross_profit": 1241542000.0, "net_income": 377031000.0, "operating_cash_flow": 400084000.0, "operating_income": 491335000.0, "revenue": 2213242000.0, "stockholders_equity": -9513000.0, "total_assets": 1537349000.0, "total_liabilities": 1546582000.0 }, "period_end": "2018-12-31", "ratio_units": { "gross_margin": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio" }, "ratios": { "gross_margin": 0.5609607986835601, "net_margin": 0.17035236092573702, "operating_margin": 0.2219978655745734, "revenue_growth_yoy": 0.1240105674896321, "roa_avg2y": 0.23196447605409803, "roa_period_end": 0.245247500730153, "roe_avg2y": -11.852779829925023 } }, { "accn": "0000874716-20-000006", "filed": "2020-02-14", "fiscal_year": 2017, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 282565000.0, "capex": 74384000.0, "cash": 187675000.0, "cost_of_revenue": 871676000.0, "eps_diluted": 2.94, "free_cash_flow": 298892000.0, "gross_profit": 1097382000.0, "net_income": 263144000.0, "operating_cash_flow": 373276000.0, "operating_income": 413028000.0, "revenue": 1969058000.0, "stockholders_equity": -54106000.0, "total_assets": 1713416000.0, "total_liabilities": 1767258000.0 }, "period_end": "2017-12-31", "ratio_units": { "gross_margin": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio" }, "ratios": { "gross_margin": 0.5573131923996144, "net_margin": 0.13363953728127867, "operating_margin": 0.20975918434093865, "revenue_growth_yoy": 0.1090641497828968, "roa_avg2y": 0.16222827762228278, "roa_period_end": 0.15357858220070317, "roe_avg2y": -3.239532679215551 } }, { "accn": "0000874716-19-000004", "filed": "2019-02-15", "fiscal_year": 2016, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "gross_profit": "USD", "net_income": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 304086000.0, "capex": 64787000.0, "cash": 154901000.0, "cost_of_revenue": 799987000.0, "eps_diluted": 2.44, "gross_profit": 975436000.0, "net_income": 222045000.0, "operating_income": 350239000.0, "revenue": 1775423000.0, "stockholders_equity": -108352000.0, "total_assets": 1530704000.0, "total_liabilities": 1638917000.0 }, "period_end": "2016-12-31", "ratio_units": { "gross_margin": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "roa_period_end": "ratio" }, "ratios": { "gross_margin": 0.5494104785169506, "net_margin": 0.12506597019414528, "operating_margin": 0.19727073491781957, "roa_period_end": 0.14506070409432523 } }, { "accn": "0000874716-15-000003", "filed": "2015-02-17", "fiscal_year": 2014, "form": "10-K", "fundamental_units": { "operating_cash_flow": "USD" }, "fundamentals": { "operating_cash_flow": 235846000.0 }, "period_end": "2014-12-31", "ratios": {} } ], "latest_filing": { "accn": "0000874716-26-000038", "filed": "2026-02-20", "form": "10-K" }, "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.", "schema_version": "1", "sic": "2835", "sic_description": "In Vitro & In Vivo Diagnostic Substances", "source_urls": { "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0000874716.json", "sec_submissions": "https://data.sec.gov/submissions/CIK0000874716.json" }, "ticker": "IDXX" }